
浏览全部资源
扫码关注微信
山西省中医院,太原 030012
冀旭艳,硕士,从事中医内科学脑病方向研究,Tel:0351-4668188,E-mail:974767428@qq.com
李宝玲,博士,主任医师,从事中医内科学脑病方向研究,Tel:0351-4668188,E-mail:15934128836@163.com
收稿日期:2021-07-06,
网络出版日期:2022-01-25,
纸质出版日期:2022-03-20
移动端阅览
冀旭艳,张恒嘉,李涛等.疏脑解郁汤对卒中后抑郁患者肠道菌群的影响[J].中国实验方剂学杂志,2022,28(06):107-113.
JI Xu-yan,ZHANG Heng-jia,LI Tao,et al.Effect of Shunao Jieyu Decoction on Intestinal Flora in Patients with Post-stroke Depression[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(06):107-113.
冀旭艳,张恒嘉,李涛等.疏脑解郁汤对卒中后抑郁患者肠道菌群的影响[J].中国实验方剂学杂志,2022,28(06):107-113. DOI: 10.13422/j.cnki.syfjx.20220695.
JI Xu-yan,ZHANG Heng-jia,LI Tao,et al.Effect of Shunao Jieyu Decoction on Intestinal Flora in Patients with Post-stroke Depression[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(06):107-113. DOI: 10.13422/j.cnki.syfjx.20220695.
目的
2
研究疏脑解郁汤对卒中后抑郁患者肠道菌群的影响。
方法
2
选择中医辨证为气郁血瘀痰阻型卒中后抑郁患者60例,按随机数字表法分为观察组与对照组各30例。观察组口服疏脑解郁汤免煎剂,对照组口服盐酸帕罗西汀片,疗程8周。比较两组治疗前后中医证候积分、汉密尔顿抑郁量表(HAMD)评分、美国国立卫生研究院卒中量表(NIHSS)评分、日常生活能力(ADL)评分的变化情况;并通过高通量测序方法对两组患者治疗前后粪便中菌群多样性及各分类学水平分布变化情况进行分析。
结果
2
①与本组治疗前比较,治疗后两组患者中医证候积分、HAMD评分、NIHSS评分均明显下降(
P
<
0.05),ADL评分明显上升(
P
<
0.05);与对照组治疗后比较,观察组中医证候积分明显降低(
P
<
0.05),HAMD评分、NIHSS评分、ADL评分差异无统计学意义;观察组总有效率为90%(27/30),对照组总有效率为66.3%(19/30),观察组优于对照组(
χ
2
=5.863,
P
<
0.05)。②治疗后观察组患者肠道菌群多样性Chao1指数、Observed species指数、Shannon指数、Simpson指数、Pielou′s enness指数组内均值均有所升高,但差异无统计学意义,Good′s coverage指数组内均值基本无变化;门水平上,拟杆菌门丰度增加;在科水平上,拟杆菌科丰度增加;在属水平上,拟杆菌属丰度增加。
结论
2
疏脑解郁汤能够有效改善卒中后抑郁患者的中医临床症状,减轻神经功能损害程度,提高日常生活能力,而且能够使患者肠道菌群的多样性及其在各分类学水平的丰度发生变化。
Objective
2
To investigate the effect of Shunao Jieyu decoction on intestinal flora in patients with post-stroke depression.
Method
2
Sixty patients with post-stroke depression of Qi stagnation, blood stasis, and phlegm obstruction were selected and divided into a treatment group (30 cases, Shunao Jieyu decoction) and a control group (
n
=30, paroxetine hydrochloride tablets) according to the random number table. All patients were treated correspondingly for eight weeks. The scores of traditional Chinese medicine(TCM) syndrome, Hamilton rating scale for depression(HAMD), National Institutes of Health stroke scale(NIHSS), and activities of daily living(ADL)before and after treatment were compared between the two groups. High-throughput sequencing was used to analyze the diversity of fecal flora and the distribution of taxonomical levels in two groups before and after treatment.
Result
2
The post-treatment TCM syndrome score, HAMD score, and NIHSS score were lower than those before treatment in the same group (
P
<
0.05), while the post-treatment ADL score was higher than that before treatment (
P
<
0.05). Compared with the control group after treatment, the treatment group showed decreased TCM syndrome score (
P
<
0.05). No significant difference was observed in the HAMD score, NIHSS score and ADL score between the two groups after treatment. The total effective rate of the treatment group was 90% (27/30), which was superior to 66.3% (19/30) of the control group (
χ
2
=5.863,
P
<
0.05). After treatment, the average values of Chao1 index, Observed species index, Shannon index, Simpson index, and Pielou's evenness index of intestinal flora diversity in the treatment group increased without significant difference, while the average value of the Good's Coverage index remained unchanged in the same group. At the phylum level, the abundance of Bacteroidetes increased. At the family level, the abundance of Bacteroidaceae increased. At the genus level, the abundance of
Bacteroidetes
increased.
Conclusion
2
Shunao Jieyu decoction can effectively improve the clinical TCM symptoms of patients with post-stroke depression, relieve neurological impairment, improve the ability of daily living, and change the diversity and abundance of the intestinal flora of patients at different taxonomic levels.
MAN S C , HUNG B H , NG R M , et al . A pilot controlled trial of a combination of dense cranial electroacupuncture stimulation and body acupuncture for post-stroke depression [J]. BMC Complement Altern Med , 2014 , 14 ( 1 ): 255 .
SCHÖTTKE H , GERKE L , DÜSING R , et al . Post-stroke depression and functional impairments-A 3-year prospective study [J]. Compr Psychiatry , 2020 , 99 : 152171 .
孟宪良 , 赵娜 , 张宁 , 等 . 卒中后抑郁的研究进展 [J]. 中国实用神经疾病杂志 , 2019 , 22 ( 18 ): 2082 - 2088 .
朱锡群 . 微生物群-脑-肠轴和中枢神经系统研究进展 [J]. 疑难病杂志 , 2018 , 17 ( 7 ): 748 - 752 .
MAYER E A . Gut feelings:the emerging biology of gut-brain communication [J]. Nat Rev Neurosci , 2011 , 12 ( 8 ): 453 - 466 .
ROGERS G B , KEATING D J , YOUNG R L , et al . From gut dysbiosis to altered brain function and mental illness:mechanisms andpathways [J]. Mol Psychiatry , 2016 , 21 ( 6 ): 738 - 748 .
JAŠAREVIĆ E , HOWERTON C L , HOWARD C D , et al . Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain [J]. Endocrinology , 2015 , 156 ( 9 ): 3265 - 3276 .
范文涛 , 闫咏梅 , 别玉龙 , 等 . 脑卒中后抑郁症患者肠道菌群的多样性分析 [J]. 南方医科大学学报 , 2016 , 36 ( 10 ): 1305 - 1311 .
李宝玲 , 郭琰 , 段婧婧 . 疏脑解郁汤治疗卒中后抑郁症的临床研究 [J]. 中西医结合心脑血管病杂志 , 2015 , 13 ( 10 ): 1162 - 1164 .
李宝玲 , 段婧婧 , 岳永花 , 等 . 疏脑解郁汤对卒中后抑郁大鼠学习记忆能力的影响及作用机理研究 [J]. 中成药 , 2016 , 38 ( 5 ): 1147 - 1150 .
李宝玲 , 卫治 , 张恒嘉 . 疏脑解郁汤对脑卒中后抑郁症大鼠6-Keto-PGF1 α 、TXB 2 水平的影响 [J]. 中西医结合心脑血管病杂志 , 2019 , 17 ( 22 ): 3518 - 3520 .
王少石 , 周新雨 , 朱春燕 . 卒中后抑郁临床实践的中国专家共识 [J]. 中国卒中杂志 , 2016 , 11 ( 8 ): 685 - 693 .
冀旭艳 , 李宝玲 . 李宝玲运用疏脑解郁汤治疗卒中后抑郁验案 [J]. 山西中医 , 2018 , 34 ( 9 ): 35 , 54 .
CLERC N , FURNESS J B . Intrinsic primary afferent neurones of the digestive tract [J]. Neurogastroenterol Motil , 2004 , 16 ( Suppl 1 ): 24 - 27 .
BERDING K , DONOVAN S M . Microbiome and nutrition in autism spectrum disorder:current knowledge and research needs [J]. Nutr Rev , 2016 , 74 ( 12 ): 723 - 736 .
罗佳 , 金锋 . 肠道菌群影响宿主行为的研究进展 [J]. 科学通报 , 2014 , 59 ( 22 ): 2169 - 2190 .
蒙丹丽 . 短链脂肪酸在肠道中的生理作用 [J]. 中国临床新医学 , 2018 , 11 ( 2 ): 198 - 202 .
WANG X , ZHANG L , LEI Y , et al . Meta-analysis of infectious agents and depression [J]. Sci Rep , 2014 , 4 : 4530 .
BÄCKHED F , DING H , WANG T , et al . The gut microbiota as an environmental factor that regulates fat storage [J]. Proc Natl Acad Sci USA , 2004 , 101 ( 44 ): 15718 - 15723 .
赵子珺 , 赵瑞珍 , 张媛 , 等 . 颐脑解郁方对缺血性脑卒中及卒中后抑郁、焦虑、痴呆大鼠宏观表征变化的干预作用 [J]. 世界中医药 , 2018 , 13 ( 12 ): 3085 - 3090,3094 .
漆靖 , 蔡溢 , 肖剑英 , 等 . 抑郁症患者肠道菌群研究 [J]. 中国微生态学杂志 , 2018 , 30 ( 9 ): 1057 - 1060 .
蒋海寅 . 人类肠道微生物群落菌群多样性变化与抑郁症的相关性研究 [D]. 杭州 : 浙江大学 , 2015 .
SCHNORR S L , BACHNER H A . Integrative therapies in anxiety treatment with special emphasis on the gut microbiome [J]. Yale J Biol Med , 2016 , 89 ( 3 ): 397 - 422 .
HOOPER L V . Bacterial contributions to mammalian gut development [J]. Trends Microbiol , 2004 , 12 ( 3 ): 129 - 134 .
SEARS C L . A dynamic partnership:celebrating our gut flora [J]. Anaerobe , 2005 , 11 ( 5 ): 247 - 251 .
HOOPER L V , WONG M H , THELIN A , et al . Molecular analysis of commensal host-microbial relationships in the intestine [J]. Science , 2001 , 291 ( 5505 ): 881 - 884 .
STAPPENBECK T S , HOOPER L V , GORDON J I . Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells [J]. Proc Natl Acad Sci USA , 2002 , 99 ( 24 ): 15451 - 15455 .
付蕾 , 冀建伟 , 郑鹏远 , 等 . 双歧杆菌对应激大鼠肠道菌群及促肾上腺皮质激素释放激素的影响 [J]. 世界华人消化杂志 , 2010 , 18 ( 15 ): 1544 - 1549 .
WALLACE C J K , MILEV R . The effects of probiotics on depressive symptoms in humans:a systematic review [J]. Ann Gen Psychiatry , 2017 , 16 : 14 .
冀旭艳 . 基于“脑-肠轴”理论探讨疏脑解郁汤治疗卒中后抑郁患者的临床疗效 [D]. 太原 : 山西省中医药研究院 , 2019 .
田祖宏 , 聂勇战 . 肠道微生物与脑-肠轴交互作用的研究进展 [J]. 传染病信息 , 2016 , 29 ( 5 ): 302 - 307 .
PETRA A I , PANAGIOTIDOU S , HATZIAGELAKI E , et al . Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation [J]. Clin Ther , 2015 , 37 ( 5 ): 984 - 995 .
范文涛 , 闫咏梅 , 别玉龙 , 等 . 大鼠卒中后肠道菌群紊乱与抑郁的关系 [J]. 中国脑血管病杂志 , 2016 , 13 ( 12 ): 644 - 649 .
LAWRENCE J G , ROTH J R . Evolution of coenzyme B12 synthesis among enteric bacteria:evidence for loss and reacquisition of a multigene complex [J]. Genetics , 1996 , 142 ( 1 ): 11 - 24 .
FANTINI J , YAHI N . Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids:common mechanisms in neurodegenerative diseases [J]. Expert Rev Mol Med , 2010 , doi: 10.1017/S1462399410001602 http://dx.doi.org/10.1017/S1462399410001602 .
0
浏览量
22
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621